Diligence memo · auto-generated · as of July 2, 2026
SalvaRx Group plc
SalvaRx Group plc looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
SalvaRx Group plc operates in Biotechnology, based in RAMSEY.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
SalvaRx Group plc has raised $340K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $340K on 2016-03-02.
Most recent recorded round closed around 2016-03-02.
Valuation (modeled)modeled
Provath models SalvaRx Group plc at approximately $19M (range $182K–$213M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.89× the median modeled value of Pre-Seed Biotechnology companies in 2016–2018 (152 peers) — value vs value, same stage and era. Within the normal band (89% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 10.3 yr ago; this sector typically re-raises about every 14 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 8% of Biotechnology peers (4293 compared).
Modeled value ranks above 27% of those peers.
Closest niche peers: New Vital Signs, Inc., Cerebral Magnetics INC, NutriBand Inc., Jivana Biotechnology Inc, AnTolRx, Inc..
Peoplefiled
6 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.